Uji klinis Hemofilia di Florida
6 studi untuk Hemofilia mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- USF Health Morsani Center For Advanced Healthcare, Tampa
- The University of South Florida Board of Trustees, Tampa
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT05568719A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- St Joseph's Children's Hospital of Tampa, Tampa
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07416604ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- dan 4 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Johns Hopkins All Children's Hospital, St. Petersburg
Menerima pesertaStudi observasional
Usia 6 hingga 19 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT05022459Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- University of Miami Miller School of Medicine, Miami
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT03695978Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- University of Miami - Miller School of Medicine, Coral Gables
- St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders, Tampa
Menerima pesertaFase 1
Usia 0 hingga 90 · Semua jenis kelamin · Diperbarui 3 Apr 2026 · NCT05500807Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.